TC BioPharm (Holdings) plc Net Income

The latest net income for TCBP is $-16M as of June 2024. That compares with $-1.7M in the prior-year period — down 847.4% year over year. That is below the sector sector average of $98M. Investors often review this figure alongside TC BioPharm (Holdings) plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, TCBP's net income moved from $-1.7M to $-16M — a 847.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TC BioPharm (Holdings) plc's operating scale or balance-sheet position.

Against its sector companies, TCBP currently prints $-16M for net income, while the sector average sits near $98M. That is roughly 116.3% below the sector mean. Large gaps often invite a closer look at TC BioPharm (Holdings) plc's growth, margins, and balance sheet.

A net income figure of $-16M for TCBP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $98M. Explore the charts below for those layers of context.

After noting TCBP's net income ($-16M), review year-over-year change from $-1.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.